To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.

Treat and Reduce Obesity Act of 2019 S.595/H.R.1530 Expanding Access to Diabetes Self-Management Training Act of 2019 S.814/H.R. 1840 To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings S.1361/H.R. 2584 Older Americans Act Programs and Services Malnutrition Quality Measures Indian Health Service Loan Repayment Program: Facility Equipment Modernization; Staff Housing Personal Protective Equipment for Older Americans Act nutrition services program workers Medical Nutrition Therapy Act of 2020 H.R. 6971 S. 4504 Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 2020 H.R. 6774 The Heroes Act H.R. 6800 H.R. 8319 Continuing Resolution and SNAP-Ed Health Care at Home Act H.R. 6644 Tele-Mental Health Improvement Act S. 3792 Consolidated Appropriations Act, 2021 H.R. 133

Client expense: Not reported · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; H.R. 8337. H.R. 133, Consolidated Appropriations Act, 2021, Public Law No: 116-260.

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, White House Office

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; HR 8337 Continuing Appropriations Act, 2021 and Other Extensions Act (issues related to expiring health programs)

Client expense: $990,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

H.R. 2584/S. 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; H.R. 8337 Continuing Appropriations Act, 2021 and Other Extensions Act (issues related to expiring health programs); H.R. 133 Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

National Parks Funding Issues; National Park Service Legacy Act (S. 751; H.R. 2584). Restore Our Parks and Public Lands Act (H.R. 1225); Restore Our Parks Act (S. 500); Land and National Park Deferred Maintenance Act (H.R. 1026).Great American Outdoors Act (S. 3422). Issues related to Commercial Use Authorization (CUAs). COVID-19 relief; CARES Act (P.L. 116-136); Families First Coronavirus Response Act (P.L. 116-127); Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123). FY 2021 Interior Appropriations (H.R. 7612). HEROES Act (H.R. 6800). Great American Outdoors Act (H.R. 1957). The revised HEROES Act (H.R. 8406). Issues related to Grand Canyon and Yellowstone National Parks.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)

National Parks Issues National Park Service Legacy Act (S. 751; HR 2584), Restore Our Parks and Public Lands Act (H.R. 1225). Restore Our Parks Act (S.500), Land and National Park Deferred Maintenance Act (H.R. 1026). Great American Outdoors Act (S. 3422). Issues related to Commercial Use Authorization (CUAs). COVID-19 relief; CARES Act (P.L. 116-136); Families First Coronavirus Response Act (P.L. 116-127); Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123). FY 2021 Interior Appropriations (H.R. 7612). HEROES Act (H.R. 6800). Great American Outdoors Act (H.R. 1957). The revised HEROES Act (H.R. 8406). Issues related to Grand Canyon and Yellowstone National Parks.

Client expense: Not reported · Firm income: $10,000

Government targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, Small Business Administration (SBA)

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions H.R 748/S. 3548, Coronavirus Aid, Relief and Economic Security Act (CARES Act), regarding all bio-pharmaceutical provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, regarding all bio-pharmaceutical related provisions

Client expense: $1,090,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

P.L. 111-375 National Alzheimer's Project Act, All Sections P.L. 115-119 Recognize, Assist, Include, Support and Engage (RAISE) Family Caregivers Act P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act P.L. 116-131 Supporting Older Americans Act of 2020 S.591 Guardianship Accountability Act S.299 Geriatrics Workforce Improvement Act S.548/H.R.1342 EMPOWER Care Act H.R.1343 Protecting Married Seniors from Impoverishment Act S.740 Alzheimer's Caregiver Support Act H.R. 1955 Understanding Appropriate Alzheimer's Care Act of 2019 S.880/H.R.1873 Improving HOPE for Alzheimer's Act S.2080/H.R.647 Palliative Care and Hospice Education and Training Act S.1250/H.R.2401 American Cures Act S.1017 Supporting America's Caregivers and Families Act S.995/H.R.2035 Lifespan Respite Care Reauthorization Act of 2019 S.1126/H.R.2283 Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2019 S.1361/H.R.2584 Preventive Health Savings Act of 2019 S.1628 Paid Family Leave Pilot Extension Act S.1618 Expanding Capacity for Health Outcomes (ECHO) Act of 2019 S.1202 Independence at Home Act of 2019 H.R.3644 Independence at Home Demonstration Act of 2019 H.R.3436 Improving Chronic Care Management Act H.R.3107 Improving Seniors' Timely Access to Care Act S.2469/H.R.4386 Stop the Wait Act H.R.2781 Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act of 2019 S.2521/H.R.4397 Direct CARE Opportunity Act S.2677 Older Americans and Social Isolation and Loneliness Act H.R.4859 Protecting Older Americans from Social Isolation Act of 2019 H.Res.821 to establish a permanent select Committee in Aging in the House of Representatives H.R.6379 Families First Coronavirus Response Act S.3548/H.R.748 Coronavirus Aid, Relief, and Economic Security (CARES) Act; including provisions that would impact individuals living with Alzheimer's and other dementia and their caregivers. H.R.4334 Supporting Older Americans Act of 2020 S.3544/H.R.6305 Coronavirus Relief for Seniors and People with Disabilities Act S.3768 /H.R.6972 Nursing Home COVID-19 Protection and Prevention Act of 2020 H.R.7048 Nursing Home Pandemic Protection Act S.3644/H.R.6698 Quality Care for Nursing Home Residents and Workers During COVID-19 Act H.R.6638 Reducing COVID-19 Disparities by Investing in Public Health H.R.7158 Health Enterprise Zones Act H.R.6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S.3517/H.R.6487 ACCESS Act S.3740/H.R.6951 COVID-19 Recovery for Seniors and People with Disabilities Act H.R.8169 Elder Abuse Protection Act S.4182 Emergency Support for Nursing Homes and Elder Justice Reform Act of 2020 H.R.5958 Senior Health Planning Account Act S.4184/H.R.7463 Assisted Living Facility Coronavirus Reporting Act S.4682/H.R.8511 Care Corp Demonstration Act of 2020 H.R. 2477 Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act In forthcoming COVID-19 relief packages, the Alzheimer's Association is advocating for inclusion of policies that would impact those in the Alzheimer's and dementia community including: - Improving HOPE for Alzheimer's Act (S.880/H.R.1873) - Extension of the Independence at Home demonstration model - Promoting Alzheimer's Awareness to Prevent Elder Abuse Act, including Elder Justice Initiative training for professionals through the Department of Justice - Emergency Preparedness in long-term and community-based care settings - Expanding Capacity for Health Outcomes (Project ECHO) - Project VITAL: Virtual Inclusive Technology for ALL

Client expense: $360,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

National Institutes of Health, Alzheimer's Disease, and the Cures Acceleration Network P.L. 112-25 Budget Control Act of 2011; provisions related to funding for non-defense discretionary programs; entitlements reform P.L. 114-255 21st Century Cures Act, P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act P.L. 116-131 Supporting Older Americans Act of 2020 Fiscal Year 2021 Labor, Health and Human Services, Education and Related Agencies Appropriations Bill; all sections related to the National Institutes of Health (NIH), Alzheimer's Disease, and the Cures Acceleration Network; Centers for Disease Control and Prevention (CDC) Fiscal Year 2021 Defense Appropriations Bill; Provisions related to the Peer Reviewed Alzheimer's Research Program Fiscal Year 2021 Interior and Environment Appropriations Bill; provisions related to the Indian Health Service and Alzheimer's disease Fiscal Year 2021 Agriculture Appropriations Bill; all sections related to the Food and Drug Administration (FDA) Fiscal Year 2021 Military Construction, Veterans Affairs and Related Agencies Appropriations Bill; provisions related to the Department of Veterans Affairs, specifically Medical and Prosthetic Research and Alzheimer's research Fiscal Year 2021 Commerce, Justice, Science, and Related Agencies Appropriations Bill; provisions related to grant program established by Kevin and Avonte's Law of 2017 S.1728/H.R.3113 Semipostal Stamp Act S.1361/H.R.2584 Preventive Health Savings Act of 2019 H.R.6379 Families First Coronavirus Response Act S.3548/H.R.748 Coronavirus Aid, Relief, and Economic Security (CARES) Act S.3544/H.R.6305 Coronavirus Relief for Seniors and People with Disabilities Act H.R.6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act In forthcoming COVID-19 relief packages the Alzheimer's Association has advocated for policies which will impact charitable nonprofits including: - Expanded Nonprofit Access to Credit: To establish an exclusive fund to support nonprofit employers with between 500 and 10,000 employees, including loan forgiveness. - Allow larger charitable nonprofits to be eligible to receive funds under the Paycheck Protection Program

Client expense: $360,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; HR 8337 Continuing Appropriations Act, 2021 and Other Extensions Act (issues related to expiring health programs)

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

National Parks Funding Issues; National Park Service Legacy Act (S. 751; H.R. 2584). Restore Our Parks and Public Lands Act (H.R. 1225); Restore Our Parks Act (S. 500); Land and National Park Deferred Maintenance Act (H.R. 1026).Great American Outdoors Act (S. 3422). Issues related to Commercial Use Authorization (CUAs). COVID-19 relief; CARES Act (P.L. 116-136); Families First Coronavirus Response Act (P.L. 116-127); Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123). FY 2021 Interior Appropriations (H.R. 7612). HEROES Act (H.R. 6800). Great American Outdoors Act (H.R. 1957). The revised HEROES Act (H.R. 8406).

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)

National Parks Issues National Park Service Legacy Act (S. 751; HR 2584), Restore Our Parks and Public Lands Act (H.R. 1225). Restore Our Parks Act (S.500), Land and National Park Deferred Maintenance Act (H.R. 1026). Great American Outdoors Act (S. 3422). Issues related to Commercial Use Authorization (CUAs). COVID-19 relief; CARES Act (P.L. 116-136); Families First Coronavirus Response Act (P.L. 116-127); Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123). FY 2021 Interior Appropriations (H.R. 7612). HEROES Act (H.R. 6800). Great American Outdoors Act (H.R. 1957). The revised HEROES Act (H.R. 8406).

Client expense: Not reported · Firm income: $10,000

Government targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, Small Business Administration (SBA)

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; H.R. 8337.

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, White House Office

Treat and Reduce Obesity Act of 2019 S.595/H.R.1530 Expanding Access to Diabetes Self-Management Training Act of 2019 S.814/H.R. 1840 To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings S.1361/H.R. 2584 Older Americans Act Programs and Services Malnutrition Quality Measures Indian Health Service Loan Repayment Program: Facility Equipment Modernization; Staff Housing Personal Protective Equipment for Older Americans Act nutrition services program workers Medical Nutrition Therapy Act of 2020 H.R. 6971 S. 4504 Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 2020 H.R. 6774 The Heroes Act H.R. 6800 H.R. 8319 Continuing Resolution and SNAP-Ed Health Care at Home Act H.R. 6644 Tele-Mental Health Improvement Act S. 3792

Client expense: Not reported · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Office of Management & Budget (OMB), SENATE

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions H.R 748/S. 3548, Coronavirus Aid, Relief and Economic Security Act (CARES Act), regarding all bio-pharmaceutical provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, regarding all bio-pharmaceutical related provisions

Client expense: $1,600,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

H.R. 2584/S. 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; H.R. 8337 Continuing Appropriations Act, 2021 and Other Extensions Act (issues related to expiring health programs)

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

P.L. 111-375 National Alzheimer's Project Act, All Sections P.L. 115-119 Recognize, Assist, Include, Support and Engage (RAISE) Family Caregivers Act P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act S.591 Guardianship Accountability Act S.299 Geriatrics Workforce Improvement Act S.548/H.R.1342 EMPOWER Care Act H.R.1343 Protecting Married Seniors from Impoverishment Act S.740 Alzheimer's Caregiver Support Act H.R. 1955 Understanding Appropriate Alzheimer's Care Act of 2019 S.880/H.R.1873 Improving HOPE for Alzheimer's Act H.R.1903/S.901 Younger-Onset Alzheimer's Disease Act of 2019 S.2080/H.R.647 Palliative Care and Hospice Education and Training Act S.1250/H.R.2401 American Cures Act S.1017 Supporting America's Caregivers and Families Act S.995/H.R.2035 Lifespan Respite Care Reauthorization Act of 2019 S.1126/H.R.2283 Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2019 S.1361/H.R.2584 Preventive Health Savings Act of 2019 S.1628 Paid Family Leave Pilot Extension Act S.1618 Expanding Capacity for Health Outcomes (ECHO) Act of 2019 S.1202 Independence at Home Act of 2019 H.R.3644 Independence at Home Demonstration Act of 2019 H.R.3436 Improving Chronic Care Management Act H.R.3107 Improving Seniors' Timely Access to Care Act H.R.4334 Dignity in Aging Act of 2019 S.2469/H.R.4386 Stop the Wait Act H.R.2781 Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act of 2019 S.2521/H.R.4397 Direct CARE Opportunity Act S.3057 Modernization of the Older Americans Act Amendments S.2677 Older Americans and Social Isolation and Loneliness Act H.R.4859 Protecting Older Americans from Social Isolation Act of 2019 H.Res.821 to establish a permanent select Committee in Aging in the House of Representatives H.R.6379 Families First Coronavirus Response Act S.3548/H.R.748 Coronavirus Aid, Relief, and Economic Security (CARES) Act; including provisions that would impact individuals living with Alzheimer's and other dementia and their caregivers. H.R.4334 Supporting Older Americans Act of 2020 S.3544/H.R.6305 Coronavirus Relief for Seniors and People with Disabilities Act S.3768 /H.R.6972 Nursing Home COVID-19 Protection and Prevention Act of 2020 H.R.7048 Nursing Home Pandemic Protection Act S.3644/H.R.6698 Quality Care for Nursing Home Residents and Workers During COVID-19 Act H.R.6638 Reducing COVID-19 Disparities by Investing in Public Health H.R.7158 Health Enterprise Zones Act H.R.6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S.3517/H.R.6487 ACCESS Act S.3740/H.R.6951 COVID-19 Recovery for Seniors and People with Disabilities Act In forthcoming COVID-19 relief packages, the Alzheimer's Association is advocating for inclusion of policies that would impact those in the Alzheimer's and dementia community including: - Improving HOPE for Alzheimer's Act (S.880/H.R.1873) - Extension of the Independence at Home demonstration model - Promoting Alzheimer's Awareness to Prevent Elder Abuse Act, including Elder Justice Initiative training for professionals through the Department of Justice - Emergency Preparedness in long-term and community-based care settings - Expanding Capacity for Health Outcomes (Project ECHO) - Project VITAL: Virtual Inclusive Technology for ALL

Client expense: $250,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

National Institutes of Health, Alzheimer's Disease, and the Cures Acceleration Network P.L. 112-25 Budget Control Act of 2011; provisions related to funding for non-defense discretionary programs; entitlements reform P.L. 114-255 21st Century Cures Act, P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act Fiscal Year 2021 Labor, Health and Human Services, Education and Related Agencies Appropriations Bill; all sections related to the National Institutes of Health (NIH), Alzheimer's Disease, and the Cures Acceleration Network; Centers for Disease Control and Prevention (CDC) Fiscal Year 2021 Defense Appropriations Bill; Provisions related to the Peer Reviewed Alzheimer's Research Program Fiscal Year 2021 Interior and Environment Appropriations Bill; provisions related to the Indian Health Service and Alzheimer's disease Fiscal Year 2021 Agriculture Appropriations Bill; all sections related to the Food and Drug Administration (FDA) Fiscal Year 2021 Military Construction, Veterans Affairs and Related Agencies Appropriations Bill; provisions related to the Department of Veterans Affairs, specifically Medical and Prosthetic Research and Alzheimer's research Fiscal Year 2021 Commerce, Justice, Science, and Related Agencies Appropriations Bill; provisions related to grant program established by Kevin and Avonte's Law of 2017 S.1728/H.R.3113 Semipostal Stamp Act S.1361/H.R.2584 Preventive Health Savings Act of 2019 H.R.6379 Families First Coronavirus Response Act S.3548/H.R.748 Coronavirus Aid, Relief, and Economic Security (CARES) Act S.3544/H.R.6305 Coronavirus Relief for Seniors and People with Disabilities Act H.R.6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act In forthcoming COVID-19 relief packages the Alzheimer's Association has advocated for policies which will impact charitable nonprofits including: - Expanded Nonprofit Access to Credit: To establish an exclusive fund to support nonprofit employers with between 500 and 10,000 employees, including loan forgiveness. - Allow larger charitable nonprofits to be eligible to receive funds under the Paycheck Protection Program

Client expense: $250,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

Treat and Reduce Obesity Act of 2019 S.595/H.R.1530 Expanding Access to Diabetes Self-Management Training Act of 2019 S.814/H.R. 1840 To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings S.1361/H.R. 2584 Older Americans Act Programs and Services Malnutrition Quality Measures Indian Health Service Loan Repayment Program: Facility Equipment Modernization; Staff Housing CARES Act H.R.748 Personal Protective Equipment for Older Americans Act nutrition services program workers Medical Nutrition Therapy Act of 2020 H.R. 6971 Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 2020 H.R. 6774 The Heroes Act H.R. 6800

Client expense: Not reported · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Office of Management & Budget (OMB), SENATE

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations.

Client expense: $650,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

National Parks Issues National Park Service Legacy Act (S. 751; HR 2584), Restore Our Parks and Public Lands Act (H.R. 1225). Restore Our Parks Act (S.500), Land and National Park Deferred Maintenance Act (H.R. 1026). Great American Outdoors Act (S. 3422). Issues related to Commercial Use Authorization (CUAs). COVID-19 relief; CARES Act (P.L. 116-136); Families First Coronavirus Response Act (P.L. 116-127); Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123). FY 2021 Interior Appropriations (H.R. 7612). HEROES Act (H.R. 6800). Great American Outdoors Act (H.R. 1957).

Client expense: Not reported · Firm income: $10,000

Government targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, Small Business Administration (SBA)

National Parks Funding Issues; National Park Service Legacy Act (S. 751; H.R. 2584). Restore Our Parks and Public Lands Act (H.R. 1225); Restore Our Parks Act (S. 500); Land and National Park Deferred Maintenance Act (H.R. 1026).Great American Outdoors Act (S. 3422). Issues related to Commercial Use Authorization (CUAs). COVID-19 relief; CARES Act (P.L. 116-136); Families First Coronavirus Response Act (P.L. 116-127); Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123). FY 2021 Interior Appropriations (H.R. 7612). HEROES Act (H.R. 6800). Great American Outdoors Act (H.R. 1957).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions H.R 748/S. 3548, Coronavirus Aid, Relief and Economic Security Act (CARES Act), regarding all bio-pharmaceutical provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, regarding all bio-pharmaceutical related provisions

Client expense: $2,160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

H.R. 2584/S. 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

National Institutes of Health, Alzheimer's Disease, and the Cures Acceleration Network P.L. 112-25 Budget Control Act of 2011; provisions related to funding for non-defense discretionary programs; entitlements reform P.L. 114-255 21st Century Cures Act, P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act Fiscal Year 2021 Labor, Health and Human Services, Education and Related Agencies Appropriations Bill; all sections related to the National Institutes of Health (NIH), Alzheimer's Disease, and the Cures Acceleration Network; Centers for Disease Control and Prevention (CDC) Fiscal Year 2021 Defense Appropriations Bill; Provisions related to the Peer Reviewed Alzheimer's Research Program Fiscal Year 2021 Interior and Environment Appropriations Bill; provisions related to the Indian Health Service and Alzheimer's disease Fiscal Year 2021 Agriculture Appropriations Bill; all sections related to the Food and Drug Administration (FDA) Fiscal Year 2021 Military Construction, Veterans Affairs and Related Agencies Appropriations Bill; provisions related to the Department of Veterans Affairs, specifically Medical and Prosthetic Research and Alzheimer's research Fiscal Year 2021 Commerce, Justice, Science, and Related Agencies Appropriations Bill; provisions related to grant program established by Kevin and Avonte's Law of 2017 S.1728/H.R.3113 Semipostal Stamp Act S.1361/H.R.2584 Preventive Health Savings Act of 2019 H.R.6379 Families First Coronavirus Response Act S.3548/H.R.748 Coronavirus Aid, Relief, and Economic Security (CARES) Act S.3544/H.R.6305 Coronavirus Relief for Seniors and People with Disabilities Act In forthcoming COVID-19 relief packages the Alzheimer's Association has advocated for policies which will impact charitable nonprofits including: - Expanded Nonprofit Access to Credit: To establish an exclusive fund to support nonprofit employers with between 500 and 10,000 employees, including loan forgiveness. - Allow larger charitable nonprofits to be eligible to receive funds under the Paycheck Protection Program

Client expense: $400,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

P.L. 111-375 National Alzheimer's Project Act, All Sections P.L. 115-119 Recognize, Assist, Include, Support and Engage (RAISE) Family Caregivers Act P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act S.591 Guardianship Accountability Act S.299 Geriatrics Workforce Improvement Act S.548/H.R.1342 EMPOWER Care Act H.R.1343 Protecting Married Seniors from Impoverishment Act S.740 Alzheimer's Caregiver Support Act H.R. 1955 Understanding Appropriate Alzheimer's Care Act of 2019 S.880/H.R.1873 Improving HOPE for Alzheimer's Act H.R.1903/S.901 Younger-Onset Alzheimer's Disease Act of 2019 S.2080/H.R.647 Palliative Care and Hospice Education and Training Act S.1250/H.R.2401 American Cures Act S.1017 Supporting America's Caregivers and Families Act S.995/H.R.2035 Lifespan Respite Care Reauthorization Act of 2019 S.1126/H.R.2283 Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2019 S.1361/H.R.2584 Preventive Health Savings Act of 2019 S.1628 Paid Family Leave Pilot Extension Act S.1618 Expanding Capacity for Health Outcomes (ECHO) Act of 2019 S.1202 Independence at Home Act of 2019 H.R.3644 Independence at Home Demonstration Act of 2019 H.R.3436 Improving Chronic Care Management Act H.R.3107 Improving Seniors' Timely Access to Care Act H.R.4334 Dignity in Aging Act of 2019 S.2469/H.R.4386 Stop the Wait Act H.R.2781 Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act of 2019 S.2521/H.R.4397 Direct CARE Opportunity Act S.3057 Modernization of the Older Americans Act Amendments S.2677 Older Americans and Social Isolation and Loneliness Act H.R.4859 Protecting Older Americans from Social Isolation Act of 2019 H.Res.821 to establish a permanent select Committee in Aging in the House of Representatives H.R.6379 Families First Coronavirus Response Act S.3548/H.R.748 Coronavirus Aid, Relief, and Economic Security (CARES) Act; including provisions that would impact individuals living with Alzheimer's and other dementia and their caregivers. H.R.4334 Supporting Older Americans Act of 2020 S.3544/H.R.6305 Coronavirus Relief for Seniors and People with Disabilities Act In forthcoming COVID-19 relief packages, the Alzheimer's Association is advocating for inclusion of policies that would impact those in the Alzheimer's and dementia community including: - Improving HOPE for Alzheimer's Act (S.880/H.R.1873) - Extension of the Independence at Home demonstration model - Promoting Alzheimer's Awareness to Prevent Elder Abuse Act, including Elder Justice Initiative training for professionals through the Department of Justice - Emergency Preparedness in long-term and community-based care settings - Expanding Capacity for Health Outcomes (Project ECHO) - Project VITAL: Virtual Inclusive Technology for ALL

Client expense: $400,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Treat and Reduce Obesity Act of 2019 S.595/H.R.1530 Expanding Access to Diabetes Self-Management Training Act of 2019 S.814/H.R. 1840 To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings S.1361/H.R. 2584 Older Americans Act Programs and Services Malnutrition Quality Measures Indian Health Service Loan Repayment Program: Facility Equipment Modernization; Staff Housing Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R.6074 Families First Coronavirus Response Act H.R.6201 CARES Act H.R.748 Personal Protective Equipment for Older Americans Act nutrition services program workers

Client expense: Not reported · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Office of Management & Budget (OMB), SENATE

H.R. 2584/S.1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in P.L. 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY 21 Labor-HHS-Education Appropriations.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appopriations.

Client expense: $610,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

National Parks Funding Issues; National Park Service Legacy Act (S. 751; H.R. 2584). Restore Our Parks and Public Lands Act (H.R. 1225); Restore Our Parks Act (S. 500); Land and National Park Deferred Maintenance Act (H.R. 1026).Great American Outdoors Act (S. 3422). Issues related to Commercial Use Authorization (CUAs). COVID-19 relief; CARES Act (P.L. 116-136); Families First Coronavirus Response Act (P.L. 116-127); Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)

National Parks Issues National Park Service Legacy Act (S. 751; HR 2584), Restore Our Parks and Public Lands Act (H.R. 1225). Restore Our Parks Act (S.500), Land and National Park Deferred Maintenance Act (H.R. 1026). Great American Outdoors Act (S. 3422). Issues related to Commercial Use Authorization (CUAs). COVID-19 relief; CARES Act (P.L. 116-136); Families First Coronavirus Response Act (P.L. 116-127); Coronavirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123).

Client expense: Not reported · Firm income: $10,000

Government targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE, Small Business Administration (SBA)

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions H.R 748/S. 3548, Coronavirus Aid, Relief and Economic Security Act (CARES Act), regarding all bio-pharmaceutical related provisions

Client expense: $540,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

H.R. 2584/S. 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); "Buy American" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE

P.L. 111-375 National Alzheimer's Project Act, All Sections P.L. 115-119 Recognize, Assist, Include, Support and Engage (RAISE) Family Caregivers Act P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act S.591 Guardianship Accountability Act S.299 Geriatrics Workforce Improvement Act S.548/H.R.1342 EMPOWER Care Act H.R.1343 Protecting Married Seniors from Impoverishment Act S.740 Alzheimer's Caregiver Support Act H.R. 1955 Understanding Appropriate Alzheimer's Care Act of 2019 S.880/H.R.1873 Improving HOPE for Alzheimer's Act H.R.1903/S.901 Younger-Onset Alzheimer's Disease Act of 2019 S.2080/H.R.647 Palliative Care and Hospice Education and Training Act S.1250/H.R.2401 American Cures Act S.1017 Supporting America's Caregivers and Families Act S.995/H.R.2035 Lifespan Respite Care Reauthorization Act of 2019 S.1126/H.R.2283 Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2019 S.1361/H.R.2584 Preventive Health Savings Act of 2019 S.1628 Paid Family Leave Pilot Extension Act S.1618 Expanding Capacity for Health Outcomes (ECHO) Act of 2019 S.1202 Independence at Home Act of 2019 H.R.3644 Independence at Home Demonstration Act of 2019 H.R.3436 Improving Chronic Care Management Act H.R.3107 Improving Seniors' Timely Access to Care Act H.R.4334 Dignity in Aging Act of 2019 S.2469/H.R.4386 Stop the Wait Act H.R.2781 Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act of 2019 S.2521/H.R.4397 Direct CARE Opportunity Act S.3057 Modernization of the Older Americans Act Amendments S.2677 Older Americans and Social Isolation and Loneliness Act H.R.4859 Protecting Older Americans from Social Isolation Act of 2019

Client expense: $400,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

National Institutes of Health, Alzheimer's Disease, and the Cures Acceleration Network P.L. 112-25 Budget Control Act of 2011; provisions related to funding for non-defense discretionary programs; entitlements reform P.L. 114-255 21st Century Cures Act, P.L. 115-406 Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act Fiscal Year 2020 Labor, Health and Human Services, Education and Related Agencies Appropriations Bill; all sections related to the National Institutes of Health (NIH), Alzheimer's Disease, and the Cures Acceleration Network; Centers for Disease Control and Prevention (CDC) Fiscal Year 2020 Defense Appropriations Bill; Provisions related to the Peer Reviewed Alzheimer's Research Program Fiscal Year 2020 Interior and Environment Appropriations Bill; provisions related to the Indian Health Service and Alzheimer's disease Fiscal Year 2020 Agriculture Appropriations Bill; all sections related to the Food and Drug Administration (FDA) Fiscal Year 2020 Military Construction, Veterans Affairs and Related Agencies Appropriations Bill; provisions related to the Department of Veterans Affairs, specifically Medical and Prosthetic Research and Alzheimer's research Fiscal Year 2020 Commerce, Justice, Science, and Related Agencies Appropriations Bill; provisions related to grant program established by Kevin and Avonte's Law of 2017 S.1728/H.R.3113 Semipostal Stamp Act S.1361/H.R.2584 Preventive Health Savings Act of 2019

Client expense: $400,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

Treat and Reduce Obesity Act of 2019 S.595/H.R.1530 Expanding Access to Diabetes Self-Management Training Act of 2019 S.814/H.R. 1840 To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings S.1361/H.R. 2584 Older Americans Act Programs and Services Malnutrition Quality Measures Indian Health Service Loan Repayment Program: Facility Equipment Modernization; Staff Housing

Client expense: $20,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Office of Management & Budget (OMB), SENATE

Preventative Health Savings Act (H.R. 2584/S. 1361)

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Preventative Health Savings Act (H.R. 2584/S. 1361)

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2584/S 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services)

Client expense: $920,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

National Parks Funding Issues; National Park Service Legacy Act (S. 751; H.R. 2584). Restore Our Parks and Public Lands Act (H.R. 1225); Restore Our Parks Act (S. 500); Land and National Park Deferred Maintenance Act (H.R. 1026).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Park Service (NPS), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT)

National Parks Issues National Park Service Legacy Act (S. 751; HR 2584), Restore Our Parks and Public Lands Act (H.R. 1225). Restore Our Parks Act (S.500), Land and National Park Deferred Maintenance Act (H.R. 1026)

Client expense: Not reported · Firm income: $10,000

Government targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE

Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Preventative Health Savings Act (H.R. 2584/S. 1361)

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE